Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple SclerosisCarmen Tur, Xavier Montalbán, Pere Carbonell‐Mirabent et al.|JAMA Neurology|2022Cited by 278
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndromeClara Matute‐Blanch, Manuel Comabella, Gleb Makshakov et al.|Brain|2018Cited by 161
The value of oligoclonal bands in the multiple sclerosis diagnostic criteriaGeorgina Arrambide, Xavier Montalbán, Mar Tintoré et al.|Brain|2018Cited by 158
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility StudyLuciana Midaglia, Michael Lindemann, Patricia Mulero et al.|Journal of Medical Internet Research|2019Cited by 141
Ocrelizumab: a new milestone in multiple sclerosis therapyPatricia Mulero, Xavier Montalbán, Luciana Midaglia|Therapeutic Advances in Neurological Disorders|2018Cited by 140